Pancreatic Cancer Research

ResearcherJohns Hopkins UniversityNo recent work listed

Siva P. Raman

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5066273842. Sources: OpenAlex.

Their work

Papers
10
Trials
0
Grants
0
Labs led
0
Collaborators
36
Papers, trials and grants by year

2012: 1 paper · 2013: 3 papers · 2014: 1 paper · 2015: 5 papers

Papers 10

  1. Phase 2 multi-institutional trial evaluating gemcitabine and stereotactic body radiotherapy for patients with locally advanced unresectable pancreatic adenocar… Co-author DOI 10.1002/cncr.29161↗
  2. Cross-sectional imaging and the role of positron emission tomography in pancreatic cancer evaluation. Co-author DOI 10.1053/j.seminoncol.2014.12.005↗
  3. The Role of Stereotactic Body Radiation Therapy for Pancreatic Cancer: A Single-Institution Experience. Co-author DOI 10.1245/s10434-014-4274-5↗
  4. Impact of the time interval between MDCT imaging and surgery on the accuracy of identifying metastatic disease in patients with pancreatic cancer. Co-author DOI 10.2214/ajr.13.12439↗
  5. Reply to "Preoperative Evaluation of Pancreatic Adenocarcinoma". Co-author DOI 10.2214/ajr.15.14643↗
  6. Baseline metabolic tumor volume and total lesion glycolysis are associated with survival outcomes in patients with locally advanced pancreatic cancer receiving… Co-author DOI 10.1016/j.ijrobp.2014.02.031↗
  7. Resection of borderline resectable pancreatic cancer after neoadjuvant chemoradiation does not depend on improved radiographic appearance of tumor-vessel relat… Co-author DOI 10.1007/s13566-013-0115-6↗
  8. Mapping patterns of local recurrence after pancreaticoduodenectomy for pancreatic adenocarcinoma: a new approach to adjuvant radiation field design. Co-author DOI 10.1016/j.ijrobp.2013.09.005↗
  9. A Phase 2 Multi-institutional Study to Evaluate Gemcitabine and Fractionated Stereotactic Radiotherapy for Unresectable, Locally Advanced Pancreatic Adenocarci… Co-author DOI 10.1016/j.prro.2013.01.016↗
  10. Multimodality imaging of pancreatic cancer-computed tomography, magnetic resonance imaging, and positron emission tomography. Co-author DOI 10.1097/ppo.0b013e318274a461↗

Closest collaborators

The 25 strongest of 36 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Joseph M. Herman · 7 shared papers, 2013–2015 · strength 0.25
  2. Christopher Lee Wolfgang · 6 shared papers, 2013–2015 · strength 0.22
  3. Elliot K. Fishman · 4 shared papers, 2012–2015 · strength 0.21
  4. Daniel A. Laheru · 6 shared papers, 2013–2015 · strength 0.21
  5. Lei Zheng · 5 shared papers, 2013–2015 · strength 0.19
  6. Avani Satish Dholakia · 5 shared papers, 2013–2015 · strength 0.17
  7. Amy Hacker‐Prietz · 4 shared papers, 2013–2015 · strength 0.14
  8. Timothy Michael Pawlik · 4 shared papers, 2013–2015 · strength 0.14
  9. Albert C. Koong · 3 shared papers, 2013–2015 · strength 0.11
  10. Daniel Tandel Chang · 3 shared papers, 2013–2015 · strength 0.11
  11. Aaron Tyler Wild · 3 shared papers, 2013–2015 · strength 0.10
  12. Lauren M. Rosati · 2 shared papers, 2015 · strength 0.08
  13. Ralph H. Hruban · 2 shared papers, 2013–2015 · strength 0.08
  14. Karyn A. Goodman · 2 shared papers, 2013–2015 · strength 0.07
  15. Dung Thi Le · 2 shared papers, 2013–2015 · strength 0.07
  16. Ana De Jesus‐Acosta · 2 shared papers, 2013–2015 · strength 0.07
  17. Christine A. Iacobuzio–Donahue · 2 shared papers, 2013–2015 · strength 0.07
  18. Susannah G. Ellsworth · 2 shared papers, 2013 · strength 0.06
  19. Karen M Horton · 1 shared paper, 2012 · strength 0.05
  20. Matthew John Weiss · 1 shared paper, 2015 · strength 0.05
  21. Sushanth Reddy · 1 shared paper, 2015 · strength 0.05
  22. Amanda L. Blackford · 1 shared paper, 2015 · strength 0.04
  23. Shalini Moningi · 1 shared paper, 2015 · strength 0.04
  24. Matthew John Weiss · 1 shared paper, 2015 · strength 0.04
  25. Eileen Mary O'Reilly · 1 shared paper, 2015 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.